| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue |
-
|
-
|
-
|
-
| | Cost of Revenue | (1,983) | 1,355 | 628 | 2,957 | | | Gross Profit | 1,983 | (1,355) | (628) | (2,957) | | | Operating Expenses | | Research Development | (11,757) | 5,914 | 5,844 | 8,475 | | Selling General and Administrative | 19,468 | 2,997 | 640 | 449 | | Non Recurring | 3,872 |
-
|
-
|
-
| | Others | 42 | 37 | 34 | 28 | | | | Total Operating Expenses | 11,624 |
-
|
-
|
-
| | | | Operating Income or Loss | (9,641) | (10,302) | (7,145) | (11,909) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 16 | 5 | 4 | 14 | | Earnings Before Interest And Taxes | (9,625) | (10,298) | (7,141) | (11,895) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (9,625) | (10,298) | (7,141) | (11,895) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (9,625) | (10,298) | (7,141) | (11,895) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (9,625) | (10,298) | (7,141) | (11,895) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($9,625) | ($10,298) | ($7,141) | ($11,895) |
|
0.02% Nasdaq 0.00%
Income Statement
